drugset / Trial / NCT05609955

Effects Of Additional MgSO4 30 Mg/KgBW Intravenous and Ketorolac

NCT05609955

Phase 4 Completed 48 enrolled Indonesia University
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to compare two groups of post-orthopedic patients who received a standard regimen, namely ketorolac 30mg, to the second group, which was given the standard regimen and adjuvant magnesium sulfate 30mg/kgBW 1 hour preoperatively. If it is proven useful, it is hoped that pain will be more controlled, reduce pain complications, reduce treatment costs, and reduce the duration of hospital stays.

Timeline

Start
2022-01-01
Primary completion
2022-10-01
Completion
2022-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 30 mg/kg Intravenous